The growth outlook for India's largest passenger carmaker - Maruti Suzuki India (MSIL) is turning the corner. While robust volumes and price hikes will drive revenue growth, moderating commodity prices and improving leverage are expected to rub off on its operating profit margins.
Brokerages have tweaked their volume growth and earnings estimates upwards after the JanuaryMarch quarter results (2021-22, or FY22) to incorporate favourable trends for the market leader.
In addition to the outlook, valuations are below the long-term average, the 14 per cent increase in its stock prices since the lows in March notwithstanding.
While supply disruption has led to a loss in production, demand trends remain strong, aided by new product launches as reflected in the order book-rising over the past few months. The order book is now at 320,000 units, compared with 240,000 in December 2021.
Since November 2021, the carmaker has launched a raft of updated and refreshed products - the Baleno, Celerio, WagonR, Dzire compressed natural gas (CNG), Ertiga, and more recently, the XL6.
The demand for CNG vehicles continues to be sturdy, with over 40 per cent of MSIL's bookings coming from this segment. The company has five cars offering CNG.
While these launches are encouraging, what the Street will be eyeing is new products in the sport utility vehicle (SUV)/multipurpose segment, whose share in the overall car market (currently at 38 per cent) continues to climb.
This story is from the May 02, 2022 edition of Business Standard.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the May 02, 2022 edition of Business Standard.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
Our sleep apnea devices safe for use in India: Philips
Dutch healthcare company Philips says it has completed remediation of its faulty sleep therapy devices in India, asserting that based on the current testing, their continued use is not expected to cause any \"appreciable\" health harm.
IPL teams' revenue dropped in FY23
The average revenue of all Indian Premier League (IPL) teams in Financial Year 202223 (FY23) was 23 per cent lower than the pre-Covid-19 year of FY19, said a report on Thursday, suggesting the popular T20 cricket tournament is \"reaching a saturation point\".
Actor Janhvi Kapoor opens home to Airbnb's 'Icons'
Homes of celebs from film, music, art, sports opened for overnight stay under new category
SKILL DRILL: FROM EDUCATION TO EMPLOYMENT
Skill-imparting companies are introducing diverse programmes to train youth for the evolving job market demands
FSSAI widens investigation to other items
After starting a probe into alleged violation of norms in branded spices, food regulator Food Safety and Standards Authority of India (FSSAI) plans to launch surveillance on other food items like fortified rice, dairy products and spices sold in the domestic market.
Manufacturing PMI eases in April
Indian manufacturing slowed down a bit in April but growth stayed robust to signal the second-best improvement in the sector's health in three and a half years, said a private business on Thursday.
OECD raises India's FY25 GDP growth projection to 6.6%
On the global front, GDP growth is projected to be 3.1% in 2024, unchanged from 2023
After split, mixed bag for Godrej shares
Share prices of Godrej Industries, Godrej Properties and Astec Lifesciences fell on Thursday after the Godrej family made the news of family settlement official.
IPO market set to break May jinx in election year
For 1st time during poll cycle since '04, mkts will see IPO frenzy
Bonds rally after Fed holds rates steady
Government bonds strengthened on Thursday as traders covered short positions following the US Federal Reserve Committee's announcement of no further rate hikes.